NCT05028712

Brief Summary

This research is aimed to address one of the big gaps in the current vision rehabilitation protocols for people with profound visual impairment by evaluating a multisensory approach. There are a growing number of clinical trials that recruit people with end-stage eye diseases and the rehabilitation plan following various treatments is not clear. It is important to address this in order to maximize the efficacy of such treatments and to improve the quality of life in people with profound visual impairment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Mar 2024Jul 2026

First Submitted

Initial submission to the registry

August 25, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 31, 2021

Completed
2.5 years until next milestone

Study Start

First participant enrolled

March 8, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

December 11, 2025

Status Verified

December 1, 2025

Enrollment Period

1.8 years

First QC Date

August 25, 2021

Last Update Submit

December 4, 2025

Conditions

Keywords

ultra low vision rehabilitationmulti sensoryfunctional vision assessment

Outcome Measures

Primary Outcomes (1)

  • Change in visual ability

    Change in visual ability as measured by the Ultra Low Vision Visual Function Questionnaire. The scale measures both visual ability (Person Measure) and difficulty (Item Measure) in people with ultra low vision. 150 items on a likert scale ranging from 1 impossible, to 4 not difficult. Using a Rasch-Andrich rating model, Person Measures range from -6 to +2.8 logits, Item Measures range from -3.3 to +3.0 logits. Higher scores indicating better outcome.

    Baseline, 1 month, 3 months, 6 months

Secondary Outcomes (2)

  • Change in hand-eye coordination

    Baseline, 1 month, 3 months, 6 months

  • Change in hearing ability

    Baseline, 1 month, 3 months, 6 months

Study Arms (2)

Visual Information Training

EXPERIMENTAL
Behavioral: Visual Information Training

Multimodal Training

EXPERIMENTAL
Behavioral: Multimodal training

Interventions

Participants in this arm will receive training to improve the use of residual vision to enhance functional performance.

Visual Information Training

Participants in this arm will receive training in integrating input from different senses to enhance functional performance.

Multimodal Training

Eligibility Criteria

Age12 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • People with ultra low vision (visual acuity ≤20/1600)

You may not qualify if:

  • \<12 years of age
  • dependent on sighted guide
  • cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUNY College of Optometry

New York, New York, 10036, United States

RECRUITING

MeSH Terms

Conditions

Vision Disorders

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Arathy Kartha, PhD

    State University of New York College of Optometry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arathy Kartha, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2021

First Posted

August 31, 2021

Study Start

March 8, 2024

Primary Completion

January 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

December 11, 2025

Record last verified: 2025-12

Locations